K-numberK250170
Device namePHAROS
ApplicantBrightonix Imaging
Product codeKPS
Device classClass II
Decision dateAug 15, 2025
DecisionSubstantially Equivalent
Regulation892.1200
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

PHAROS is a dedicated PET (Positron Emission Tomography) scanner that detects the distribution of radioactivity in specific body regions (brain, breast, arms, and legs) after injection of a positron-emitting radiopharmaceutical. It produces high-resolution 3D images to assist in diagnosis, therapeutic planning, and outcome assessment.

Technological characteristics

Both PHAROS and the predicate BBX-PET use pixelated scintillation crystals coupled to silicon photomultipliers in a circular gantry design. Key differences: PHAROS uses single-layer crystals versus the predicate's dual-layer crystals; PHAROS has a larger bore diameter (320 mm vs. 288 mm) and extended axial field-of-view; PHAROS includes Time-of-Flight functionality and a variable patient chair, whereas the predicate uses manual positioning. PHAROS demonstrates superior performance specifications (higher sensitivity, better scatter fraction control, time resolution <275 ps).

Test standards cited

IEC 60601-1 and IEC 60601-1-2 for electrical safety and electromagnetic compatibility; NEMA NU2:2018 and NEMA NU4:2008 for PET performance; ISO 10993-1 for biocompatibility; IEC 62304 for software verification and validation; ISO 14971 for risk management.

Substantial equivalence argument

Both devices are Class II emission computed tomography systems with identical product codes (KPS) and similar indications for use. They employ the same fundamental PET detection principle using scintillation crystals and photomultipliers in a circular configuration. Although PHAROS incorporates design improvements (single-layer crystal, larger bore, TOF capability, integrated chair) that enhance performance metrics, these differences are attributed to normal design evolution and do not introduce new safety or effectiveness risks. The device passed all required performance tests, clinical images demonstrated acceptability, and performance testing confirmed it is at least as safe and effective as the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →